Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 149,000 | 78,000 | 198,000 | 101,000 | 346,000 |
| Depreciation Amortization | 14,000 | 12,000 | 12,000 | 6,000 | 32,000 |
| Accounts receivable | -27,000 | -38,000 | -43,000 | -35,000 | -9,000 |
| Accounts payable and accrued liabilities | 142,000 | 72,000 | 55,000 | 43,000 | 145,000 |
| Other Working Capital | 338,000 | 255,000 | 13,000 | 8,000 | 127,000 |
| Other Operating Activity | -209,000 | -99,000 | -52,000 | -26,000 | -321,000 |
| Operating Cash Flow | $407,000 | $280,000 | $183,000 | $97,000 | $320,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,000 | -23,000 | -13,000 | -4,000 | -27,000 |
| Purchase Sale Intangibles | -15,000 | N/A | N/A | N/A | -4,000 |
| Other Investing Activity | -15,000 | 0 | 0 | 0 | -4,000 |
| Investing Cash Flow | $-35,000 | $-23,000 | $-13,000 | $-4,000 | $-31,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -78,000 | -69,000 | -60,000 | -17,000 | -112,000 |
| Dividend Paid | -69,000 | -69,000 | N/A | N/A | -23,000 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -9,000 |
| Financing Cash Flow | $-147,000 | $-138,000 | $-60,000 | $-17,000 | $-144,000 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -9,000 |
| Beginning Cash Position | 467,000 | 467,000 | 467,000 | 467,000 | 331,000 |
| End Cash Position | 692,000 | 586,000 | 577,000 | 543,000 | 467,000 |
| Net Cash Flow | $225,000 | $119,000 | $110,000 | $76,000 | $136,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 407,000 | 280,000 | 183,000 | 97,000 | 320,000 |
| Capital Expenditure | -20,000 | -23,000 | -13,000 | -4,000 | -27,000 |
| Free Cash Flow | 387,000 | 257,000 | 170,000 | 93,000 | 293,000 |